GS0421: Research, product development and product development consultation regarding pharmaceutical, biological, gene therapy and biotechnological products
Case File Event Statements
6/6/2014 - 10 years ago
23 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9Type:CAEX
6/6/2012 - 12 years ago
22 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN
4/9/2009 - 15 years ago
21 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.Type:C15A